Search Results - "DeWald, Tracy A."

Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure by Jentzer, Jacob C., MD, DeWald, Tracy A., RD, PharmD, BCPS, Hernandez, Adrian F., MD

“…Volume overload is an important clinical target in heart failure management, typically addressed using loop diuretics. An important and challenging subset of…”
Get full text

The pharmacology of novel oral anticoagulants by DeWald, Tracy A., Becker, Richard C.

“…Anticoagulation for the prevention of stroke is an important aspect of the management of atrial fibrillation. Novel anticoagulants including oral factor Xa…”
Get full text

Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients by Granger, Bradi B., RN, MSN, PhD, Ekman, Inger, PhD, Hernandez, Adrian F., MD, MHS, Sawyer, Tenita, BSN, RN, Bowers, Margaret T., DNP, RN, DeWald, Tracy A., PharmD, Zhao, Yanfang, MS, Levy, Janet, PhD, Bosworth, Hayden B., PhD

“…Background Poor adherence to evidence-based medications in heart failure (HF) is a major cause of avoidable hospitalizations, disability, and death. To test…”
Get full text

Pharmacotherapy in Medicare beneficiaries with atrial fibrillation by Piccini, Jonathan P., MD, MHS, Mi, Xiaojuan, PhD, DeWald, Tracy A., PharmD, Go, Alan S., MD, Hernandez, Adrian F., MD, MHS, Curtis, Lesley H., PhD

“…Background There are limited data regarding national patterns of pharmacotherapy for atrial fibrillation (AF) among older patients. Drug exposure data are now…”
Get full text

Cardiohepatic Interactions in Heart Failure by Samsky, Marc D., MD, Patel, Chetan B., MD, DeWald, Tracy A., PharmD, Smith, Alastair D., MB, ChB, Felker, G. Michael, MD, MHS, Rogers, Joseph G., MD, Hernandez, Adrian F., MD, MHS

“…Heart failure (HF) is a major public health problem leading to frequent hospitalizations, impaired quality of life, and shortened life expectancy. Heart…”
Get full text

Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure—Reply by Mentz, Robert J, DeWald, Tracy A, Velazquez, Eric J

Get full text

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications by SAMSKY, Marc D, PATEL, Chetan B, DEWALD, Tracy A, SMITH, Alastair D, FELKER, G. Michael, ROGERS, Joseph G, HERNANDEZ, Adrian F

“…Heart failure (HF) is a major public health problem leading to frequent hospitalizations, impaired quality of life, and shortened life expectancy. Heart…”
Get full text

Management of Heart Failure With Reduced Ejection Fraction by Rashid, Ahmed Mustafa, Khan, Muhammad Shahzeb, Fudim, Marat, DeWald, Tracy A., DeVore, Adam, Butler, Javed

“…Heart failure with reduced ejection fraction (HFrEF) is a complex and progressive clinical condition characterized by dyspnea and functional impairment. HFrEF…”
Get full text

Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? by Bhatt, Ankeet S, DeVore, Adam D, DeWald, Tracy A, Swedberg, Karl, Mentz, Robert J

“…Heart failure (HF) is associated with significant morbidity and mortality. Although initially thought to be harmful in HF, beta-adrenergic blockers…”
Get full text

Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications by DeWald, Tracy A, Washam, Jeffrey B, Becker, Richard C

“…Anticoagulant medications are used widely for a variety of medical and surgical diseases, disorders, and conditions associated with thrombosis and…”
Get full text

Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients by Shah, Nishant P., Page, Courtney, Green, Cynthia L., Gao, Michael, Cavalier, Joanna, McGarrah, Robert W., DeWald, Tracy A., Sangvai, Devdutta, Patel, Manesh R., Pagidipati, Neha J.

“…Guidelines recommend aggressive low-density lipoprotein cholesterol (LDL-C) lowering in patients with atherosclerotic cardiovascular disease (ASCVD). However,…”
Get full text

An evaluation of torsemide in patients with heart failure and renal disease by Peters, Anthony E, Mentz, Robert J, DeWald, Tracy A, Greene, Stephen J

“…Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl- cotransporter type 2 in the thick ascending loop of Henle, leading to increased excretion of urinary…”
Get more information

Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial by Greene, Stephen J., Velazquez, Eric J., Anstrom, Kevin J., Clare, Robert M., DeWald, Tracy A., Psotka, Mitchell A., Ambrosy, Andrew P., Stevens, Gerin R., Rommel, John J., Alexy, Tamas, Ketema, Fassil, Kim, Dong-Yun, Desvigne-Nickens, Patrice, Pitt, Bertram, Eisenstein, Eric L., Mentz, Robert J.

“…Loop diuretics are a primary therapy for the symptomatic treatment of heart failure (HF), but whether torsemide improves patient symptoms and quality of life…”
Get full text

Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy by Cooper, Lauren, DeVore, Adam, Cowger, Jennifer, Pinney, Sean, Baran, David, DeWald, Tracy A, Burt, Tara, Pietzsch, Jan B, Walton, Antony, Aaronson, Keith, Shah, Palak

“…Approximately 1/3 of patients with acute decompensated heart failure (ADHF) are discharged with persistent congestion. Worsening renal function (WRF) occurs in…”
Get full text

Body surface area and medication dosing in patients with heart failure with reduced ejection fraction by Brooksbank, Jeremy A., Greene, Stephen J., DeWald, Tracy A., Mentz, Robert J.

“…Multiple medications are proven to reduce morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF), but data regarding…”
Get full text

Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction by Carnicelli, Anthony P., Clare, Robert M., Hofmann, Paul, Chiswell, Karen, DeVore, Adam D., Vemulapalli, Sreekanth, Felker, G. Michael, Kelsey, Anita M., DeWald, Tracy A., Sarocco, Phil, Mentz, Robert J.

“…Recent data suggest that patients with heart failure with reduced ejection fraction (HFrEF) and worsening heart failure (WHF) have potential for greater…”
Get full text

Anticoagulants by DeWald, Tracy A., PharmD, MHS, Washam, Jeffrey B., PharmD, Becker, Richard C., MD

“…Anticoagulant medications are used widely for a variety of medical and surgical diseases, disorders, and conditions associated with thrombosis and…”
Get full text

Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients by Bhatt, Ankeet S., MD, MBA, DeVore, Adam D., MD, MHS, DeWald, Tracy A., PharmD, MHS, Swedberg, Karl, MD, PhD, Mentz, Robert J., MD

“…Abstract Heart failure (HF) is associated with significant morbidity and mortality. Although initially thought to be harmful in HF, beta-adrenergic blockers…”
Get full text

Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease by Steinberg, Benjamin A, Broderick, Samuel H, Lopes, Renato D, Shaw, Linda K, Thomas, Kevin L, DeWald, Tracy A, Daubert, James P, Peterson, Eric D, Granger, Christopher B, Piccini, Jonathan P

“…Atrial fibrillation (AF) and coronary artery disease (CAD) are common in older patients. We aimed to describe the use of antiarrhythmic drug (AAD) therapy and…”
Get full text

Efficacy and safety of nesiritide in patients with acute decompensated heart failure by DeWald, Tracy A, Hernandez, Adrian F

“…Acute decompensated heart failure is a common clinical problem with associated poor outcomes. Over the last decade, attention to this area has greatly…”
Get more information